Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
A 1mL (100 unit) syringe handles all doses reconstituted at 5mg/mL up to 5mg per injection
500 Additionally, PepGens PGN-EDO51, designed to skip exon 51 in the DMD gene, has shown promising results in Phase I clinical trials and is now in Phase II (NCT06079736)
//Cagrilintide Cagrilintide 1415456-99-3 1415456-99-3 5000 1g 2g 3g 2026-06-26 17653471880 [email protected] : Cagrilintide CAS 1415456-99-3 -20 98% CAS 1415456-99-3 Cagrilintide Pyr-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe- Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-OH(Disulfide bridgeCys2-Cys7) 98.0% / Cagrilintide -20 0.3% VIP 2026-08-04 42 VIP 2026-08-03 6000 1415456-99-3 VIP 2026-08-03 5000 VIP 2026-08-03 1415456-99-3 VIP 2026-08-03 100 /1415456-99-3/Cagrilintide/ VIP 2026-08-02 500 2026-08-02 1415456-99-3 VIP 2026-08-01 3300 1415456-99-3 Cagrilintide VIP 2026-07-31 4800 1415456-99-3Cagrilintide VIP 2026-07-31 100
KotoglouPKalaitzakisAVezyrakiPTzavarasTMichalisLKDantzerFet al
These microbial changes significantly enhance GLP-1 activity (Xu et al., 2019)
US$ 20.96
US$ 29.03
US$ 21.69
US$ 28.11
US$ 20.33
US$ 21.46
